DocMorris AG (XSWX:DOCM) ROCE % : -14.79% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DocMorris AG's annualized ROCE % for the quarter that ended in Dec. 2023 was -14.79%.

DocMorris AG ROCE % Historical Data

The historical data trend for DocMorris AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG ROCE % Chart

DocMorris AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-6.47

-12.47

-19.33

-15.83

-12.89

DocMorris AG Semi-Annual Data
	Dec12	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-26.84	-13.04	-19.04	-9.81	-14.79

DocMorris AG ROCE % Calculation

DocMorris AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-99.518	/	( ( (1099.445 - 241.349)	+	(866.423 - 180.319) )	/ 2 )
	=	-99.518	/	( (858.096	+	686.104)	/ 2 )
	=	-99.518	/	772.1
	=	-12.89 %

DocMorris AG's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-114.596	/	( ( (1010.521 - 147.134)	+	(866.423 - 180.319) )	/ 2 )
	=	-114.596	/	( ( 863.387	+	686.104 )	/ 2 )
	=	-114.596	/	774.7455
	=	-14.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

DocMorris AG (XSWX:DOCM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DocMorris AG ROCE % Related Terms

Thank you for viewing the detailed overview of DocMorris AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

DocMorris AG (XSWX:DOCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ZRSEF:USA DOCMz:UK

Address

Walzmuhlestrasse 60, Frauenfeld, CHE, 8500

Website

https://www.zurrosegroup.com

DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines